scholarly article | Q13442814 |
P819 | ADS bibcode | 2012PLoSO...742506B |
P356 | DOI | 10.1371/JOURNAL.PONE.0042506 |
P932 | PMC publication ID | 3419735 |
P698 | PubMed publication ID | 22916131 |
P5875 | ResearchGate publication ID | 230724257 |
P50 | author | Anita Hokken-Koelega | Q110439807 |
P2093 | author name string | Alberto Edefonti | |
Franz Schaefer | |||
Kitty J Jager | |||
Karlijn J van Stralen | |||
Enrico Verrina | |||
Elena A Molchanova | |||
Marjolein Bonthuis | |||
P2860 | cites work | Euro-Growth references for length, weight, and body circumferences. Euro-Growth Study Group | Q47234584 |
Reference values for height, weight and body mass index of German born Turkish children. | Q47262621 | ||
Prevalence of overweight among children in Europe | Q47358659 | ||
Height of conscripts in Europe: is postneonatal mortality a predictor? | Q47363367 | ||
Height, weight, body mass index and pubertal development reference values for children of Turkish origin in the Netherlands | Q47443849 | ||
Variation of growth in height and weight of children. II. After infancy | Q47446812 | ||
Variation of growth in length and weight of children. I. Years 1 and 2. | Q47446825 | ||
Evaluation of the feasibility of international growth standards for school-aged children and adolescents | Q48420001 | ||
[Heights and weights of Danish children] | Q50555484 | ||
Reliability of three length measurement techniques in term infants. | Q52912462 | ||
Statistical agreement and cost-benefit: Comparison of methods for constructing growth reference charts. | Q53183915 | ||
Vekstkurver for norske barn | Q57420660 | ||
Growth in Turkish children in Stockholm | Q58135692 | ||
Secular change in adult stature has come to a halt in northern Europe and Italy | Q58816431 | ||
Using the new UK-WHO growth charts | Q59401652 | ||
WHO Child Growth Standards in action | Q59419603 | ||
Continuing Positive Secular Growth Change in the Netherlands 1955–1997 | Q59419665 | ||
Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development | Q69639409 | ||
The Euro-Growth Study: why, who, and how | Q74005517 | ||
Assessment of differences in linear growth among populations in the WHO Multicentre Growth Reference Study | Q79831933 | ||
Worldwide practices in child growth monitoring | Q79886564 | ||
The secular trend in human physical growth: a biological view | Q80819879 | ||
The 6th nationwide anthropological survey of children and adolescents in the Czech Republic in 2001 | Q80915664 | ||
[Spanish cross-sectional growth study 2008. Part II. Height, weight and body mass index values from birth to adulthood] | Q81468478 | ||
Growth charts compared | Q82820621 | ||
KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary | Q83385679 | ||
A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format | Q24791531 | ||
2000 CDC Growth Charts for the United States: methods and development | Q29614506 | ||
Maternal and child undernutrition: global and regional exposures and health consequences | Q29615511 | ||
CDC growth charts: United States | Q29615833 | ||
Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee | Q29619180 | ||
Persistent variations in average height between countries and between socio-economic groups: an overview of 10 European countries | Q33913746 | ||
Secular trends in growth. | Q34006787 | ||
Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). | Q34564139 | ||
Cross sectional stature and weight reference curves for the UK, 1990 | Q34796371 | ||
The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration | Q35564926 | ||
Harmonizing national growth references for multi-centre surveys, drug monitoring and international postmarketing surveillance. | Q35700735 | ||
Measuring nutritional status in children with chronic kidney disease | Q35901527 | ||
Interpopulation variation in height among children 7 to 18 years of age. | Q36760152 | ||
Implications of adopting the WHO 2006 Child Growth Standard in the UK: two prospective cohort studies | Q36869135 | ||
Development of a WHO growth reference for school-aged children and adolescents | Q37085013 | ||
Growth and puberty in German children: is there still a positive secular trend? | Q37265805 | ||
Secular changes in human biological variables in Western countries: an updated review and synthesis. | Q37637781 | ||
Current indications for growth hormone therapy for children and adolescents | Q37762676 | ||
Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States | Q37787037 | ||
Indications for growth hormone therapy in children | Q37871735 | ||
Development of an evidence-based clinical practice guideline on linear growth measurement of children | Q37897364 | ||
Height, weight, body mass index and pubertal development references for children of Moroccan origin in The Netherlands. | Q39011268 | ||
Secular changes in growth and maturation: an update. | Q40875640 | ||
German height references for children aged 0 to under 18 years compared to WHO and CDC growth charts. | Q43715436 | ||
Growth of preterm and full-term children aged 0-4 years: integrating median growth and variability in growth charts | Q43901438 | ||
The LMS method for constructing normalized growth standards | Q44055571 | ||
The influence of secular trend for height on ascertainment and eligibility for growth hormone treatment | Q44541281 | ||
Growth of Belgian and Norwegian children compared to the WHO growth standards: prevalence below -2 and above +2 SD and the effect of breastfeeding | Q45192971 | ||
References for growth and pubertal development from birth to 21 years in Flanders, Belgium | Q46420692 | ||
Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference | Q47178668 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e42506 | |
P577 | publication date | 2012-08-15 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Use of national and international growth charts for studying height in European children: development of up-to-date European height-for-age charts | |
P478 | volume | 7 |
Q47676953 | Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease |
Q37426919 | Adult height in patients with advanced CKD requiring renal replacement therapy during childhood |
Q31116103 | Age Dependency of GLI Reference Values Compared with Paediatric Lung Function Data in Two German Studies (GINIplus and LUNOKID). |
Q40443145 | Age- and sex-related growth patterns of the craniofacial complex in European children aged 3-6 years |
Q38134289 | Assessment of nutritional status in children with chronic kidney disease and on dialysis. |
Q93060042 | Association between intestinal worm infection and malnutrition among rural children aged 9-11 years old in Guizhou Province, China |
Q40882952 | Can school health check-ups serve as screening tool for growth anomalies and obesity in children? |
Q47395570 | Can the height-independent Pottel eGFR equation be used as a screening tool for chronic kidney disease in children? |
Q92734235 | Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease |
Q61454187 | Comparison of Slovak reference values for anthropometric parameters in children and adolescents with international growth standards: implications for the assessment of overweight and obesity |
Q40996451 | Considerable variations in growth hormone policy and prescription in paediatric end-stage renal disease across European countries-a report from the ESPN/ERA-EDTA registry. |
Q92111006 | Determinants of Statural Growth in European Children With Chronic Kidney Disease: Findings From the Cardiovascular Comorbidity in Children With Chronic Kidney Disease (4C) Study |
Q89553827 | Dieting, body weight concerns and health: trends and associations in Swedish schoolchildren |
Q92543232 | Early or Late Transplantation in Congenital Nephrotic Syndrome: Which is Effective for Optimal Growth? |
Q98466369 | Establishment of Z Score Reference of Growth Parameters for Egyptian School Children and Adolescents Aged From 5 to 19 Years: A Cross Sectional Study |
Q36222614 | Final height in Italian patients with congenital hypothyroidism detected by neonatal screening: a 20-year observational study. |
Q34660166 | Geographical Differences in the Population-Based Cross-Sectional Growth Curve and Age at Peak Height Velocity with respect to the Prevalence Rate of Overweight in Japanese Children |
Q53233020 | Growth charts for Australian children with achondroplasia. |
Q43770418 | Growth in children with chronic kidney disease: 13 years follow up study. |
Q34936233 | Growth monitoring: a survey of current practices of primary care paediatricians in Europe |
Q39538590 | Growth reference for Saudi school-age children and adolescents: LMS parameters and percentiles |
Q40593752 | Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA Registry. |
Q38615675 | Lessons learned from the ESPN/ERA-EDTA Registry. |
Q36952375 | Natural history of alpha mannosidosis a longitudinal study |
Q61813906 | Normative growth charts for Shwachman-Diamond syndrome from Italian cohort of 0-8 years old |
Q38639631 | Outcomes of renal replacement therapy in boys with prune belly syndrome: findings from the ESPN/ERA-EDTA Registry. |
Q36872771 | Polish 2012 growth references for preschool children |
Q52655244 | Secular Trends on Birth Parameters, Growth, and Pubertal Timing in Girls with Turner Syndrome. |
Q36046588 | Short Stature: Comparison of WHO and National Growth Standards/References for Height |
Q40617208 | Should children with overweight or obesity be excluded from height references? |
Q35168288 | Should the WHO growth charts be used in France? |
Q87238950 | Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period |
Q37189565 | The LMS and Z scale growth reference for Saudi school-age children and adolescents |
Q37472945 | The effect of recombinant human iduronate-2-sulfatase (Idursulfase) on growth in young patients with mucopolysaccharidosis type II. |
Q35961479 | The height-, weight- and BMI-for-age of preschool children from Nizhny Novgorod city, Russia, relative to the international growth references |
Q31137941 | Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS1: data from the ESPN/ERA-EDTA Registry. |
Q44762138 | Underweight, overweight and obesity in paediatric dialysis and renal transplant patients. |
Q90464437 | Updates to pediatric hypertension guidelines: influence on classification of high blood pressure in children and adolescents |
Q43446026 | Weight and height percentiles calculated by the LMS method in Argentinean schoolchildren. A comparative references study |
Search more.